RecruitingPhase I/IIEN originalLeukemia

CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this phase I/II clinical trial is to test CARCIK-CD123/33 cells to treat patients with R/R AML/BPDCN, who have otherwise exhausted conventional treatment options. In particular, this study will assess the safety and feasibility of CARCIK-CD123/33 cells infusion in adults and children with R/R AML, ahead of scheduled alloHCT.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek od 6 miesięcy do 75 lat
  • •Aktywna białaczka ostra (AML) lub białaczka dendryto-komórkowa (BPDCN) z widocznymi komórkami nowotworowymi w szpiku i/lub we krwi
  • •Choroba oporna na leczenie lub nawrót po co najmniej dwóch liniach terapii
  • •Możliwość znalezienia dawcy szpiku (co najmniej częściowo zgodny genetycznie)
  • •Komórki nowotworowe wykazujące markery CD123 i CD33 potwierdzone badaniem laboratoryjnym
  • •Możliwość otrzymania przeszczepu szpiku w przyszłości
  • •Zadowalająca funkcja serca i płuc
  • •Zgodna informowana zgoda rodzica/opiekuna (dla dzieci) lub pacjenta

Simplified criteria — AI translation

Trial details

Minimum age
6 Months
Maximum age
75 Years
Last updated (source)
October 16, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (2)

Fondazione IRCCS San Gerardo dei Tintori

Monza, Italy

ASST Papa Giovanni XXIII

Bergamo, Italy

Trial contact

Giorgio Antonio Ottaviano, Medicine

PRINCIPAL_INVESTIGATOR

Benedetta Rambaldi, Medicine

Benedetta Rambaldi, Medicine

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/17/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.